62 related articles for article (PubMed ID: 10904987)
21. Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.
Reiter LA; Robinson RP; McClure KF; Jones CS; Reese MR; Mitchell PG; Otterness IG; Bliven ML; Liras J; Cortina SR; Donahue KM; Eskra JD; Griffiths RJ; Lame ME; Lopez-Anaya A; Martinelli GJ; McGahee SM; Yocum SA; Lopresti-Morrow LL; Tobiassen LM; Vaughn-Bowser ML
Bioorg Med Chem Lett; 2004 Jul; 14(13):3389-95. PubMed ID: 15177439
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Huijun W; Long C; Zhigang Z; Feng J; Muyi G
Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
[TBL] [Abstract][Full Text] [Related]
24. Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells.
Tsukinoki T; Sugiyama H; Sunami R; Kobayashi M; Onoda T; Maeshima Y; Yamasaki Y; Makino H
Clin Exp Nephrol; 2004 Sep; 8(3):196-205. PubMed ID: 15480896
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model.
Syk I; Agren MS; Adawi D; Jeppsson B
Br J Surg; 2001 Feb; 88(2):228-34. PubMed ID: 11167872
[TBL] [Abstract][Full Text] [Related]
26. Role of matrix metalloproteinases in viral-associated glomerulonephritis.
Wörnle M; Roeder M; Sauter M; Ribeiro A
Nephrol Dial Transplant; 2009 Apr; 24(4):1113-21. PubMed ID: 19004847
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of cyclosporin A inhibition of the cytokine-induced matrix metalloproteinase-9 in glomerular mesangial cells.
Doller A; Akool el-S; Müller R; Gutwein P; Kurowski C; Pfeilschifter J; Eberhardt W
J Am Soc Nephrol; 2007 Feb; 18(2):581-92. PubMed ID: 17202418
[TBL] [Abstract][Full Text] [Related]
28. [Role of matrix metalloproteinases in the progression of renal lesions].
Marti HP
Presse Med; 2000 Apr; 29(14):811-7. PubMed ID: 10816726
[TBL] [Abstract][Full Text] [Related]
29. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease.
Kurogi Y
Med Res Rev; 2003 Jan; 23(1):15-31. PubMed ID: 12424751
[TBL] [Abstract][Full Text] [Related]
30. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.
Matyszak MK; Perry VH
J Neuroimmunol; 1996 Sep; 69(1-2):141-9. PubMed ID: 8823386
[TBL] [Abstract][Full Text] [Related]
31. Effect of dilazep hydrochloride, an antiplatelet agent, on the proliferation of cultured mouse glomerular mesangial cells.
Gohda T; Makita Y; Shike T; Funabiki K; Horikoshi S; Shirato I; Tomino Y
Nephron; 2000 Jan; 84(1):90-1. PubMed ID: 10644919
[No Abstract] [Full Text] [Related]
32. The novel synthetic inhibitor of matrix metalloproteinases Ro 28-2653 induces apoptosis in Dunning tumor cells.
Mangoldt D; Sinn B; Lein M; Krell HW; Schnorr D; Loening SA; Jung K
Apoptosis; 2002 Jun; 7(3):217-20. PubMed ID: 11997665
[TBL] [Abstract][Full Text] [Related]
33. [Is local antiproteolytic failure the cause of a prolonged course in various forms of glomerulonephritis?].
Kuźniar J; Szewczyk Z
Wiad Lek; 1990 Jun; 43(11):521-6. PubMed ID: 2219918
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel mesangial cell proliferation inhibitors using a three-dimensional database searching method.
Kurogi Y; Miyata K; Okamura T; Hashimoto K; Tsutsumi K; Nasu M; Moriyasu M
J Med Chem; 2001 Jul; 44(14):2304-7. PubMed ID: 11428924
[TBL] [Abstract][Full Text] [Related]
35. New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases.
Marti HP
Schweiz Med Wochenschr; 2000 May; 130(21):784-8. PubMed ID: 10904987
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells.
Daniel C; Duffield J; Brunner T; Steinmann-Niggli K; Lods N; Marti HP
J Pharmacol Exp Ther; 2001 Apr; 297(1):57-68. PubMed ID: 11259528
[TBL] [Abstract][Full Text] [Related]
37. The role of matrix metalloproteinases in the activation of mesangial cells.
Marti HP
Transpl Immunol; 2002 May; 9(2-4):97-100. PubMed ID: 12180853
[TBL] [Abstract][Full Text] [Related]
38. Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cells.
Eberhardt W; Kilz T; Akool el-S; Müller R; Pfeilschifter J
Biochem Pharmacol; 2005 Aug; 70(3):433-45. PubMed ID: 15963473
[TBL] [Abstract][Full Text] [Related]
39. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
[TBL] [Abstract][Full Text] [Related]
40. Role of matrix metalloproteinases in mesangial proliferative glomerulonephritis.
Marti HP
Kidney Blood Press Res; 2000; 23(3-5):199-201. PubMed ID: 11031721
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
